MRP Capital Investments’s Moderna MRNA Stock Holding History

MRP Capital Investments’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.5K	Buy	+50	New	+$2.59K	﹤0.01%	205
2025 Q3	–	Sell	-50	Closed	-$1.38K	–	212
2025 Q2	$1.38K	Buy	+50	New	+$1.32K	﹤0.01%	179
2025 Q1	–	Sell	-50	Closed	-$2.08K	–	226
2024 Q4	$2.08K	Buy	+50	New	+$2.39K	﹤0.01%	205
2023 Q3	–	Sell	-50	Closed	-$6.08K	–	165
2023 Q2	$6.08K	Sell	50 -3,610	-99%	-$482K	0.01%	212
2023 Q1	$562K	Sell	3,660 -1,060	-22%	-$175K	0.62%	58
2022 Q4	$848K	Buy	+4,720	New	+$772K	0.94%	34

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

MRP Capital Investments's MRNA Position: Q2 2026 in Review

MRP Capital Investments opened a new position in Moderna (MRNA) in Q2 2026: 50 shares worth $3.5K. The stake represents ﹤0.01% of the portfolio and ranks #205 among its holdings. This is a return to the name: MRP Capital Investments previously reported a position in MRNA as recently as Q2 2025.

MRP Capital Investments first reported a position in MRNA in Q4 2022 and has held it in 6 quarters since. The position peaked at $848K in Q4 2022. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

MRP Capital Investments held 50 shares of Moderna worth $3.5K as of Q2 2026.
Moderna was a new MRP Capital Investments position in Q2 2026.
Moderna made up ﹤0.01% of MRP Capital Investments's portfolio in Q2 2026, its #205 holding.
MRP Capital Investments first reported a position in Moderna in Q4 2022 and has held it in 6 quarters since.
MRP Capital Investments's Moderna position peaked at $848K in Q4 2022.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MRP Capital Investments's 13F filing for Q2 2026, filed 10 Aug 2026.